Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: From prohibition to conditional indications

British Journal of Ophthalmology

Volumn 96, Issue 8, 2012, Pages 1078-1083

  Munier, Francis L ^a   Gaillard, Marie Claire ^a   Balmer, Aubin ^a   Soliman, Sameh ^a,b   Podilsky, Gregory ^c   Moulin, Alexandre P ^a   Beck Popovic, Maja ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; EYE PHOTOGRAPHY; EYE TOXICITY; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINOBLASTOMA; RETINOPATHY; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; SURVIVAL RATE; TUMOR SEEDING; VITREOUS DISEASE; VITREOUS HEMORRHAGE;

ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD, PRESCHOOL; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTRAVITREAL INJECTIONS; MALE; MELPHALAN; NEOPLASM SEEDING; RETINAL NEOPLASMS; RETINOBLASTOMA; RETREATMENT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VITREOUS BODY;

EID: 84864831608     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-301450     Document Type: Article

References (22)

1. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64. (Pubitemid 34462014)
2. Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol 2004;122:1316-23. (Pubitemid 39180851)
3. Shields CL, Honavar SG, Shields JA, et al. Factors predictive of recurrence of retinal tumors, vitreous seeds and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002;120:460-4. (Pubitemid 34727817)
4. Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006;113:2276-80. (Pubitemid 44838917)
5. Lumbroso-Le Rouic L, Aers I, Lévy-Gabriel C, et al. Conservative treatments of intraocular retinoblastoma. Ophthalmology 2008;115:1405-10.
6. Beck Popovic M, Abouzeid H, Gaillard MC, et al. Criteria defining the duration of chemoreduction with focal treatment in retinoblastoma. (submitted).
7. Abramson D, Marr B, Dunkel I, et al. Intra-arterial chemotherapy for retinoblastoma eyes with vitreous and/or subretinal seeding Br J Ophthalmol 2012;96:499-502.
8. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: Report No. 1, Control of retinal tumors, subretinal seeds, and vitreous seeds Arch Ophthalmol 2011;129:1399-406.
9. Munier FL, Beck-Popovic M, Balmer A, et al. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization following superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina 2011;31:566-73.
10. Suzuki S, Yamane T, Mohri M, et al. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology 2011;118:2081-7.
11. Gombos DS, Cauchi PA, Hungerford JL, et al. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor? Br J Ophthalmol 2006;90:1168-72. (Pubitemid 44351151)
12. Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol 2003;33:601-7. (Pubitemid 43102812)
13. Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured retinoblastoma cells in a human clonogenic assay. Jpn J Cancer Res 1987;78:858-68. (Pubitemid 17124771)
14. Ueda M, Tanabe J, Inomata M, et al. Study on conservative treatment of retinoblastoma - effect of intravitreal injection of melphalan on the rabbit retina. Nippon Ganka Gakkai Zasshi 1995;99:1230-5.
15. Munier FL, Soliman S, Moulin A, et al. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilization of the needle track. Br J Ophthalmol 2012;96:1084-7.
16. Moulin AP, Gaillard MC, Balmer A, et al. Ultrasound biomicroscopy evaluation of anterior extension in retinoblastoma: a clinicopathological study. Br J Ophthalmol 2012;96:337-40.
17. Pica A, Moeckli R, Balmer A, et al. Preliminary experience in the treatment of papillary and macular retinoblastoma: evaluation of tumor control and local complications after treatment with LINAC based stereotactic radiation therapy with a micromultileaf collimator. Int J Radiat Oncol Biol Phys 2011;81:1380-6.
18. Chan HS, Gallie BL, Munier FL, et al. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am 2005;18:55-63. (Pubitemid 40348810)
19. Ericson LA, Rosengren BH. Present therapeutic resources in retinoblastoma. Acta Ophthalmol 1961;39:569-76.
20. Seregard S, Kock E, af Trampe E. Intravitreal chemotherapy for recurrent retinoblastoma in an only eye. Br J Ophthalmol 1995;79:194-5.
21. Kivela T, Eskelin S, Paloheimo M. Intravitreal Methotrexate for retinoblastoma. Ophthalmology 2011;118:1689.
22. Suzuki S, Kaneko A. Vitreous injection therapy of melphalan for retinoblastoma. XVth Biannual Meeting ISOO, 14-17 November 2011, Buenos Aires. Abstract 1352 RB34. http://www.isoo.info/image/users/123602/ftp/my-files/ ICOO%202011/ProgramaISOO2011.pdf?id=9467349 (accessed 19 Apr 2012).